These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 6170001)
1. [Serum AFP determination in pregnant women]. Huisjes HJ; de Bruijn HW; Ruitenberg EJ Ned Tijdschr Geneeskd; 1981 Sep; 125(37):1500-1. PubMed ID: 6170001 [No Abstract] [Full Text] [Related]
2. [Screening of pregnant women for fetal neural tube defects by determination of the serum alpha fetoprotein level]. Los FJ; Hagenaars AM; Huisjes HJ; de Bruyn HW; Ruitenberg EJ Ned Tijdschr Geneeskd; 1980 Jul; 124(27):1096-101. PubMed ID: 6157115 [No Abstract] [Full Text] [Related]
3. [Solid-phase immunoenzyme analysis of alpha-fetoprotein in human blood serum]. Shevtsova AI; Demchenko TV; Lapa TV Lab Delo; 1990; (5):52-5. PubMed ID: 1695975 [TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women. Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126 [TBL] [Abstract][Full Text] [Related]
5. [Determination of alpha-fetoprotein in the serum of pregnant women by rocket-linear immunoelectrophoresis]. Demchenko TV; Shevtsova AI; Berezin VA; Voronin KV; Usenko LV Vopr Med Khim; 1986; 32(1):39-42. PubMed ID: 2420066 [TBL] [Abstract][Full Text] [Related]
7. Screening model of studying alpha-foetoprotein of maternal serum (S-AFP) organized within central dispensary follow-up of pregnant women in Baranya region. Kóbor J; Pejtsik B; Pácsa S Sante Publique (Bucur); 1982; 25(3):193-9. PubMed ID: 6187074 [No Abstract] [Full Text] [Related]
8. [Antenatal screening for neural tube defect by measuring alphafetoprotein in dried blood eluates (author's transl)]. Augier D; Dutau G; Petrus M; Grandjean H; Pontonnier G; Rochiccioli P Arch Fr Pediatr; 1981 Dec; 38(10):757-60. PubMed ID: 6174100 [TBL] [Abstract][Full Text] [Related]
9. [Success in informing pregnant women concerning blood alpha fetoprotein determination for the detection of neural tube defects in the fetus]. Tijmstra T; Huisjes HJ Ned Tijdschr Geneeskd; 1983 Mar; 127(13):541-5. PubMed ID: 6188959 [No Abstract] [Full Text] [Related]
10. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)? Sancken U; Bartels I Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279 [TBL] [Abstract][Full Text] [Related]
11. Recurrent false-positives in AFP screening for open neural tube defects. Wald NJ; Huttly WJ; Rudnicka AR Prenat Diagn; 2004 Dec; 24(12):1018-9. PubMed ID: 15614882 [No Abstract] [Full Text] [Related]
12. Biochemical screening of congenital developmental abnormalities using determination of fetoplacental antigens. Fialová L; Malbohan I; Mikulíková L; Hájek Z Acta Univ Carol Med (Praha); 1993; 39(1-4):3-8. PubMed ID: 9355657 [TBL] [Abstract][Full Text] [Related]
20. [Maternal serum screening for Down syndrome and neural tube defects]. van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]